BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 26940738)

  • 1. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
    Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
    Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.
    Zhang P; Huang C; Fu C; Tian Y; Hu Y; Wang B; Strasner A; Song Y; Song E
    Oncotarget; 2015; 6(12):9834-53. PubMed ID: 25868853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.
    Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP
    Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1.
    Yu H; Gao G; Cai J; Song H; Ma Z; Jin X; Ji W; Pan B
    Exp Mol Pathol; 2019 Jun; 108():143-149. PubMed ID: 31022384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
    Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
    Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.
    Zhang X; Wei C; Li J; Liu J; Qu J
    Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1.
    Li J; Khan MA; Wei C; Cheng J; Chen H; Yang L; Ijaz I; Fu J
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29207526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.
    Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L
    Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.